Current plan
Explorer
Upgrade
payment warning Payment details required
limit warning One or more limits reached
Daily profile views
0 / 3
Monthly profile views
0 / 15
Searches (last 30 days)
0 / 10
No linked companies
Get featured as a Team Member in a Finder company.
Team Member at
Add Entity
snc-logo

Startup Nation Finder

My Watchlists
Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
Saved Searches
Following
Messaging
Notifications
About Us
Glossary
Current plan
Explorer
Pricing plans
warning Payment details required
Daily profile views
0 / 3
Monthly profile views
0 / 15
Searches (last 30 days)
0 / 10

Your CSV is on the way

We’ve sent your CSV file to
send file

Upgrade your Finder plan

  • ✓Basic CSV download
  • ✓Unlimited profile visits
  • ✓Unlimited searches
  • ✓Ecosystem reports
  • ✓Saved searches, Watchlists & notifications

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
0/300
Notifications Settings
Public content (accessible by all Finder users)

Add to List

    Notifications settings

    Set Notifications
    Off
    Select notifications to recieve tooltip-info
    Select all

    Email Alerts

    Receive notifications via email

    No Notifications are selected

    Would you like to select any notifications?
    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to email@email.com
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    email@email.com

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Dynamic List | Current Companies undefined
    Auto-updated as companies match your search. Ideal for tracking a market of interest
    Search Description
    undefined
    Search must have a valid name.
    Receive notifications via email

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    snackbar-icon
    title
    message
    Home > Multinationals > Quark Pharmaceuticals
    Claimed by owner • Last Update Jun 11, 2023 • Suggest Edits • Claim Profile
    Claimed by owner
    Quark Pharmaceuticals

    Quark Pharmaceuticals

    Pharmaceuticals • United States

    CEASED TO OPERATE IN ISRAEL tooltip-info May 2022
    Terms of Use
    Quark Pharmaceuticals
    About
    Portfolio Exits
    Israeli Portfolio
    News
    Gallery
    Jul 19, 2018
    globenewswire.com
    Quark Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
    #Investment #Partners
    Jan 13, 2014
    www.globes.co.il
    Quark Pharmaceuticals merged with Japan's SBI
    #Partners #Expand

    About

    Quark Pharmaceuticals, Inc. is a late clinical-stage pharmaceutical company, a leader in the discovery and development of novel RNAi-based therapeutics for unmet medical needs. Two products, which were granted Orphan designation, QPI -1002 and QP -1007 are in global phase III pivotal clinical studies for Delayed Graft Function (DGF) and Non Arteritic Ischemic Optic Neuropathy (NAION) respectively.

    QBI Enterprises Ltd is Quark'sIsraeli research and developmentcenter.QBI has a fully integrated drug development platform thatspans from therapeutic target identification to drug development.

    Founded

    In Israel Since

    Employees Worldwide

    Employees In Israel

    Country

    United States

    News

      (2)
    Jul 19, 2018
    globenewswire.com
    Quark Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 3 Clinical Trial of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
    #Investment #Partners
    Jan 13, 2014
    www.globes.co.il
    Quark Pharmaceuticals merged with Japan's SBI
    #Partners #Expand

    The Team

    (2)
    DZ
    Daniel Zurr
    CEO & Founder at QBI Enterprises
    HA
    Hagit Asush
    VP of R&D

    Connect with

    What is the reason for connecting? *
    Please select a reason
    Your company *
    Please fill out this field

    Your organization type *

    Please fill out this field
    Please select a type
    Your position *
    Please fill out this field
    Add invitation message
    0/300

    Sending invitation...

    Portfolio Exits

    Public Offering
    $50M
    Apr 2018
    Stock Exchange
    NASDAQ logo
    NASDAQ
    Valuation Undisclosed
    $50M

    Israeli Portfolio

    (1)
    Company Name Description Founded Business Model Employees Funding Stage Raised
    Eloxx Pharmaceuticals logo
    Eloxx Pharmaceuticals
    Treatment of Rare Genetic Diseases 2013 B2B 11-50 Public $98.5M

    Locations

    Israel

    Weizmann/Science Park, Ness Ziona

    Offices Abroad

    7999 Gateway Boulevard, Newark, CA, USA

    Locations

    Israel

    Weizmann/Science Park, Ness Ziona

    Offices Abroad

    7999 Gateway Boulevard, Newark, CA, USA

    Notes

    Content Writer
    undefined
    BI Verification
    undefined
    Phone Number
    undefined
    Israel Register ID
    undefined
    Confidence Score
    undefined
    Missing Fields
    undefined
    Profile Creator
    undefined
    Profile Update
    undefined
    undefined

    Add Article

    0/500